Securities to be offered to employees in employee benefit plans

style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">

As filed with the Securities and Exchange Commission on June 14 , 2019

Registration No. 333-

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

INFUSYSTEM HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

20-3341405

(State or other jurisdiction of

Incorporation or organization)

(I.R.S. Employer Identification No.)

31700 Research Park Drive Madison Heights, Michigan

48071

(Address of Principal Executive Offices)

(Zip Code)

InfuSystem Holdings, Inc. 2014 Equity Plan

(Full title of the plan)

Gregory Schulte

Chief Financial Officer

31700 Research Park Drive

Madison Heights, Michigan 48071

(Name and address of agent for service)

(248) 291-1210

(Telephone number, including area code, of agent for service)

with copies of communications to:

B. Scott Gootee , Esq.

Scot Hill , Esq.

Stinson LLP

1201 Walnut, Suite 2900

Kansas City, Missouri 64106

(816) 842-8600

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.


CALCULATION OF REGISTRATION FEE

Title of securities to be registered

Amount to be

registered (1)

Proposed

maximum

offering price

per share (2 )

Proposed

maximum

aggregate offering

price (2 )

Amount of

registration

fee (3)

Common Stock, par value $.0001 per share

1,000,000

shares

$4.47

$4,470,000.00

$541.77

(1)

In the event of a stock split, stock dividend or similar transaction involving the Registrant’s Common Stock, in order to prevent dilution, the number of shares of Common Stock registered hereby shall be automatically increased to cover the additional shares of Common Stock in accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”).

(2)

Calculated pursuant to Rules 457(h)(1) and 457(c) under the Securities Act based on the average of the high and low prices reported for the Registrant’s Common Stock on June 12, 2019 on the NYSE American. Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457 under the Securities Act.

(3)

Calculated pursuant to General Instruction E to Form S-8.

EXPLANATORY NOTE

This Registration Statement on Form S-8 is being filed by InfuSystem Holdings, Inc. (the “Registrant”) for the purpose of registering an additional 1,000,000 shares of the Registrant’s Common Stock reserved for issuance under the InfuSystem Holdings, Inc. 2014 Equity Plan (as amended through May 15, 2019), as approved by the Registrant’s stockholders at the Registrant’s 2019 annual meeting of stockholders.

Pursuant to General Instruction E to Form S-8, this Registration Statement on Form S-8 incorporates by reference the contents of the Registration Statement on Form S-8 (File No. 333-195929) filed by the Registrant with the Securities and Exchange Commission (the “Commission”) on May 13, 2014.


PART II


INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 8.  Exhibits.

Exhibit
Number

Description of Exhibit

4.1

Amended and Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-35020) as filed with the Commission on May 12, 2014).

4.2

Amended and Restated By-Laws, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-35020) as filed with the Commission on July 9, 2018).

5.1*

Opinion of Stinson LLP regarding legality.

23.1*

Consent of BDO USA, LLP.

23.2*

Consent of Stinson LLP (contained in Exhibit 5.1 hereto).

24.1*

Powers of Attorney (contained in the signature page hereto).

99.1 Composite Copy of InfuSystem Holdings, Inc. 2014 Equity Plan, as amended (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-35020) as filed with the Commission on May 17, 2019).

* Filed herewith.


SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Madison Heights, State of Michigan, on this 14th day of June, 2019.

INFUSYSTEM HOLDINGS, INC.

By:

/s/ Richard A. DiIorio

Richard A. DiIorio

President, Chief Executive Officer


POWER OF ATTORNEY

Each person whose signature appears below hereby constitutes and appoints Richard A. DiIorio and Gregory Schulte, and each of them, his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

Signatures

Title

Date

/s/ Richard A. DiIorio

President, Chief Executive Officer

June 14, 2019

Richard A. DiIorio

(Principal Executive Officer) and Director

/s/ Gregory Schulte

Executive Vice President, Chief Financial Officer

June 14, 2019

Gregory Schulte

(Principal Financial Officer and Principal Accounting Officer)

/s/ Scott Shuda

Chairman of the Board and Director

June 14, 2019

Scott Shuda

/s/ Gregg Lehman

Vice Chairman of the Board and Director

June 14, 2019

Gregg Lehman

/s/ Paul Gendron

Director

June 14, 2019

Paul Gendron

/s/ Darrell B. Montgomery

Director

June 14, 2019

Darrell B. Montgomery

/s/ Christopher R. Sansone

Director

June 14, 2019

Christopher R. Sansone

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever InfuSystems Holdings makes a similar move, sign up!

Other recent filings from the company include the following:

InfuSystems Holdings's Executive VP and COO just declared owning 69,636 shares of InfuSystems Holdings - Oct. 9, 2019
InfuSystems: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC - Oct. 2, 2019
InfuSystems Holdings's President and CEO just picked up 33,632 shares - Sept. 30, 2019
InfuSystems: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC - Sept. 30, 2019

Auto Refresh

Feedback